![Michael Mullette](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Mullette active positions
Companies | Position | Start | End |
---|---|---|---|
Lykos Therapeutics PBC
![]() Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Chief Operating Officer | 01/03/2022 | - |
Career history of Michael Mullette
Former positions of Michael Mullette
Companies | Position | Start | End |
---|---|---|---|
MODERNA, INC. | Corporate Officer/Principal | - | - |
Statistics
International
United States | 3 |
Operational
Corporate Officer/Principal | 1 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MODERNA, INC. | Health Technology |
Private companies | 1 |
---|---|
Lykos Therapeutics PBC
![]() Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Health Technology |
- Stock Market
- Insiders
- Michael Mullette
- Experience